Stock Price
2.89
Daily Change
-3.34%
Yearly
-15.50%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Jiangsu Hengrui Me. 46.65 -0.83 -1.75% -57.53%
AbbVie 133.52 -3.77 -2.75% 19.61%
Agenus 2.89 -0.10 -3.34% -15.50%
Amgen 230.85 -0.91 -0.39% -4.47%
AstraZeneca 8,471.00 22.00 0.26% 11.58%
Bristol-Myers Squibb 64.60 -0.22 -0.34% -2.15%
ChemoCentryx 33.31 0.96 2.97% -47.45%
Celldex Therapeutics 30.12 -1.32 -4.20% 67.52%
CSL 276.00 -5.70 -2.02% 3.27%
Dicerna Pharmaceuticals 38.22 0.22 0.58% 71.54%
Dynavax Technologies 13.06 -0.55 -4.04% 154.09%
Flexion Therapeutics 9.12 -0.02 -0.22% -17.76%
Gilead Sciences 71.88 -0.37 -0.51% 15.19%
Genocea Biosciences 1.01 -0.05 -4.72% -65.76%
GlaxoSmithKline 1,635.60 4.40 0.27% 15.70%
Glaxosmithkline 45.06 -0.18 -0.40% 18.08%
Immunogen 6.46 -0.37 -5.42% -14.78%
Incyte Corp 73.65 0.03 0.04% -19.98%
J&J 168.76 -1.03 -0.61% 5.05%
Karyopharm Therapeutics 8.03 -0.32 -3.83% -47.58%
Eli Lilly 249.67 -6.25 -2.44% 33.74%
MacroGenics 14.03 -0.11 -0.78% -31.96%
Merck 195.35 -1.20 -0.61% 31.20%
Merck & Co 81.32 0.12 0.15% -1.03%
Novartis 82.02 -0.48 -0.58% -3.85%
Novavax 112.38 -17.79 -13.67% -13.54%
Northwest Biotherapeutics 0.79 0.03 3.97% -40.30%
Pfizer 55.54 -1.11 -1.96% 51.13%
Regeneron Pharmaceuticals 616.11 -15.33 -2.43% 18.96%
Rigel Pharmaceuticals 2.31 -0.08 -3.35% -39.37%
Sangamo BioSciences 6.24 -0.06 -0.95% -61.46%
Veracyte 29.47 -2.55 -7.96% -43.95%
Acceleron Pharma 178.75 -0.93 -0.52% 57.43%
Intrexon 3.08 -0.04 -1.28% -64.23%

Indexes Price Day Year
NASDAQ 14807 -381.58 -2.51% 12.92%
US2000 2159 -16.62 -0.76% 0.19%

Agenus
Agenus Inc. (Agenus) is a clinical-stage immuno-oncology (I-O) company. It has a pipeline of immune checkpoint antibodies, adoptive cell therapies and neoantigen cancer vaccines, to fight cancer. Its I-O assets include antibody-based therapeutics, monospecific and bispecific antibodies, cell therapy, neoantigen cancer vaccines (individualized and off-the shelf) platforms and adjuvants. Its anti-PD-1 antibody and first-generation and next generation anti-CTLA-4 antagonists are in clinical development. Its pipeline of pre-clinical assets, which include AGEN1777, an anti-TIGIT bispecific antibody and AGEN1327, an anti-TIGIT monospecific antibody. Its neoantigen vaccine platforms include its heat shock protein (HSP) based Prophage vaccine candidates and its synthetic, neoantigen vaccine candidates, AutoSynVax (ASV) and PhosphoSynVax (PSV). Its neoantigen vaccine platforms include individualized ASV and off-the-shelf PSV, which target antigens expressed across patients and tumors.